Mutares' Share Price Sits at a Crossroads as a 100 Million Euro Catalyst Hangs in the Balance

Mutares trades near 52-week low despite deal flurry; NEM exit and H2 2026 earnings hold key to reversal.

The gap between what Mutares is doing and what its share price is saying has rarely been wider. Over the past few weeks, the Munich-based holding company has signed a carsharing deal with Stellantis, closed the acquisition of Sabic's Engineering Thermoplastics business, and agreed to buy Synthomer's Czech acrylate monomer operations. Yet the equity trades at €25.90, roughly 26 percent below its 52-week high of €35.15 and beneath both its 50-day and 200-day moving averages.

Wednesday brought another 2.3 percent decline, a move market observers attribute to lingering valuation concerns, speculation about delays in the planned NEM exit, and worries over integration risk at the newly acquired NexPoint business. With a price-to-earnings ratio for 2026 estimated at just 2.32 — a historic low — the market is effectively pricing in a high degree of skepticism about management's ability to deliver on its stated targets.

The Second-Half Pivot

The bull case rests almost entirely on the second half of 2026. Management has reaffirmed its full-year guidance, pointing to a significantly stronger H2 driven by the full consolidation of Nord Gas Solutions and NexPoint, the former Sabic division now rebranded as Engineering Thermoplastics. The company has also confirmed full compliance with all bond covenants as of June 30, 2026, a formal resolution of the balance-sheet concerns that weighed on the stock earlier this year.

The single most important catalyst, however, is the planned exit from NEM. Management expects the sale, slated for the third quarter of 2026, to contribute more than €100 million to adjusted net income. That figure would dwarf the first-half result, which came in at just €6 million — a steep drop from €70 million a year earlier, largely because the anticipated one-off gains from the Steyr exit failed to materialize.

Should the NEM sale close on schedule, the story gains its most powerful near-term validation. The segment revenue for Chemicals & Materials could eventually surpass the €2 billion mark, and the current share price — with an RSI of 34.7 suggesting oversold conditions — would look like an entry point near the 52-week low of €23.30.

Integration Risk and Lingering Drags

The bear case is equally concrete. Acquisitions of NexPoint's scale — the deal closed at an enterprise value of $450 million and spans operations across Europe and the US — typically generate friction costs before synergies emerge. Any visible integration hiccup could undermine confidence in the broader turnaround narrative.

The NEM exit is another vulnerability. There is currently no confirmed delay, but speculation alone has been enough to pressure the stock. If the timeline slips, the company loses its most important short-term earnings driver, and the second-half rebound management has promised would lose its foundation.

The retail segment continues to weigh on results as well. Lapeyre, the French DIY chain, remains loss-making. Management has signaled a long-term divestment, but no timetable has been set. Meanwhile, Automotive & Mobility shows modest revenue improvement, though the broader market environment stays challenging.

A Mixed Scorecard

The first-half numbers, published on August 18, illustrate the complexity of the situation. Revenue climbed to €3.4 billion from €3.1 billion in the prior-year period, yet EBITDA fell sharply to €349 million from €598 million. CIO Johannes Laumann described segment performance as uneven, and financial circles have increasingly focused on balance-sheet quality, with potential writedowns at Lapeyre and the group's liquidity position drawing particular attention.

The acquisition spree continues regardless. On June 19, Mutares agreed to purchase Synthomer's Czech acrylate monomer business, a transaction born from the seller's strategic portfolio pruning. The Sabic Engineering Thermoplastics acquisition closed on Monday, establishing the new Chemicals & Materials segment. The recent completion of the Car Top Systems purchase from Magna International further broadens the group's industrial footprint.

What Comes Next

The immediate test is the NEM exit. If it delivers the promised €100 million-plus inflow, the weak H1 figures become a footnote and the second-half acceleration becomes reality. If it slips, the shares likely resume their slide toward the 52-week low.

The next formal checkpoint is the Capital Markets Day in London on November 19, 2026, where management is expected to provide updates on the NEM exit, NexPoint integration, and the Free2Move transaction, which remains subject to antitrust approval and is slated to close by the end of 2026. Until then, the stock remains a bet on execution — on deals announced but not yet fully realized, and on a turnaround story that the market has yet to embrace.

One side note that has drawn attention in Frankfurt: CFO Mark Friedrich's total compensation rose to €2.3 million for fiscal 2025, up from €1.7 million the prior year. And for those tracking former holdings, Steyr Motors lowered its two-year outlook last Friday — though Mutares, having sold its remaining stake in November 2025, is no longer exposed to that particular disappointment.